Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Sep 17;587(18):3021-6.
doi: 10.1016/j.febslet.2013.07.029. Epub 2013 Jul 23.

Additivity-based design of the strongest possible turkey ovomucoid third domain inhibitors for porcine pancreatic elastase (PPE) and Streptomyces griseus protease B (SGPB)

Affiliations

Additivity-based design of the strongest possible turkey ovomucoid third domain inhibitors for porcine pancreatic elastase (PPE) and Streptomyces griseus protease B (SGPB)

Mohammad A Qasim et al. FEBS Lett. .

Abstract

We describe here successful designs of strong inhibitors for porcine pancreatic elastase (PPE) and Streptomyces griseus protease B (SGPB). For each enzyme two inhibitor variants were designed. In one, the reactive site residue (position 18) was retained and the best residues were substituted at contact positions 13, 14, and 15. In the other variant the best residues were substituted at all contact positions except the reactive site where a Gly was substituted. The four designed variants were: for PPE, T(13)E(14)Y(15)-OMTKY3 and T(13)E(14)Y(15)G(18)M(21)P(32)V(36)-OMTKY3, and for SGPB, S(13)D(14)Y(15)-OMTKY3 and S(13)D(14)Y(15)G(18)I(19)K(21)-OMTKY3. The free energies of association (ΔG(0)) of expressed variants have been measured with the proteases for which they were designed as well as with five other serine proteases and the results are discussed.

Keywords: Additivity; CARL; HLE; Inhibitor design; Kazal inhibitor; OMTKY3; PPE; Protease inhibitor; SGPA and SGPB; SRA; Serine protease; Streptomyces griseus protease A and B. In MEROPS database and recent literature these are listed as Streptogrisin A and B; human leukocyte elastase; porcine pancreatic elastase; sequence to reactivity algorithm; subtilisin Carlsberg; turkey ovomucoid third domain.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Primary structure of expressed wtOMTKY3. The first five residues are not shown because they are not part of the expressed OMTKY3 (and its variants) and have been found to have no effect on the inhibitory activity of OMTKY3. The residues are numbered sequentially as well as in Schechter-Berger notation [30]. In Schechter-Berger notation, the reactive site residue (shown by the arrow) is labeled as P1. Residues towards the N-terminal of the P1 residue are sequentially labeled as P2, P3, …Pn whereas residues C-terminal to P1 residue are labeled as P1', P2', … Pn'. The amino acids shown as filled circles are the consensus contact residues in inhibitor-protease complexes. The two filled circles shown in grey color represent the residues which in addition to being the contact residues also play a structural role.

Similar articles

References

    1. Laskowski M, Jr, Kato I. Protein inhibitors of proteinases. Annu. Rev. Biochem. 1980;49:593–626. - PubMed
    1. Read RJ, James MNG. Introduction to the protein inhibitors: x-ray crystallography. In: Barrett AJ, Salvesen G, editors. Proteinase Inhibitors. Amsterdam: Elsevier Science Publishers B. V.; 1986. pp. 301–336.
    1. Laskowski M, Jr, Qasim MA, Lu S. Interaction of standard mechanism, canonical protein inhibitors with serine proteinases. In: Kleanthous C, editor. Protein-protein recognition. Oxford: Oxford University Press; 2000. pp. 228–279.
    1. Otlewski J, Jelen F, Zakrzewska M, Oleksy A. The many faces of proteaseprotein inhibitor interaction. EMBO J. 2005;24:1303–1310. - PMC - PubMed
    1. Laskowski M, Jr, Qasim MA. What can the structures of enzyme-inhibitor complexes tell us about the structures of enzyme substrate complexes? Biochim. Biophys. Acta - Protein Structure and Molecular Enzymology. 2000;1477:324–337. - PubMed

Publication types

MeSH terms